>We had four papers with original data this year so far, in Cell Death and Differentiation, Oncogene, Journal of Cell Science and, as I informed Prof Wilkins this week, one accepted with the EMBO Journal. I was also the editor of a book and wrote two reviews. Doesn’t count.
>This leads to a interesting spin to the old saying “publish or perish”. Here it is “publish and perish”.
Sad to think that incredible contributions like that are still not enough to be deemed an essential part of a research department.
If he was able to publish at that scale with the grants he was getting, then that's not only perfectly alright, but it's damned impressive.
Incredibly unfortunate to hear of his passing, even worse that the circumstances aren't clear.
One of the fun things about the price mechanism is that it reduces everything down to its valuation in currency. Ethics, knowledge, emotion. It's terribly convenient.
>This leads to a interesting spin to the old saying “publish or perish”. Here it is “publish and perish”.
Sad to think that incredible contributions like that are still not enough to be deemed an essential part of a research department.
If he was able to publish at that scale with the grants he was getting, then that's not only perfectly alright, but it's damned impressive.
Incredibly unfortunate to hear of his passing, even worse that the circumstances aren't clear.